Cipla Medpro signed collaboration pact with Teva for selling drugs in South Africa
Cipla Medpro announced that it has inked a collaboration pact with Teva Pharmaceuticals of Israel for sales and distribution of the latter's drugs in South Africa.
Cipla Medpro on 9 October 2014 announced that it has inked a collaboration pact with Teva Pharmaceuticals of Israel for sales and distribution of the latter's drugs in South Africa.
Medpro Pharmaceuticals, a subsidiary of Cipla Medpro and Teva Pharmaceuticals pty of Teva Pharmaceuticals Industries signed a sales and distribution agreement. The collaboration is a subject to the approval by the Competition Commission of South Africa.
According to agreement, Cipla Medpro will exclusively market Teva's broad pharmaceutical product portfolio in South Africa and provides affordable medicines in South Africa.
The collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality products.
About Cipla Medpro
Medpro Pharmaceutical (Pty) Ltd - a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa.
Cipla Medpro manufactures world class pharmaceuticals at cost-effective prices, making quality medicines affordable, and advancing healthcare for all South Africans.
About Teva Pharmaceuticals
Teva Pharmaceuticals (Pty) Ltd is an affiliate of Teva Pharmaceutical Industries Ltd (Teva) of Israel. Teva is the largest generic pharmaceutical manufacturer in the world with a presence in about 60 countries.